Black Diamond Therapeutics Inc (BDTX)
2.40
-0.03
(-1.23%)
USD |
NASDAQ |
Nov 21, 12:16
Black Diamond Therapeutics Price: 2.40 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 2.55 | 2.56 | 2.38 | 2.43 | 468945.0 |
Nov 19, 2024 | 2.53 | 2.638 | 2.48 | 2.55 | 481123.0 |
Nov 18, 2024 | 2.63 | 2.68 | 2.485 | 2.50 | 486282.0 |
Nov 15, 2024 | 2.86 | 2.86 | 2.615 | 2.62 | 442206.0 |
Nov 14, 2024 | 3.12 | 3.125 | 2.835 | 2.85 | 446512.0 |
Nov 13, 2024 | 3.22 | 3.32 | 3.10 | 3.13 | 336368.0 |
Nov 12, 2024 | 3.36 | 3.44 | 3.19 | 3.24 | 393500.0 |
Nov 11, 2024 | 3.33 | 3.43 | 3.22 | 3.38 | 403175.0 |
Nov 08, 2024 | 3.16 | 3.38 | 3.16 | 3.29 | 535556.0 |
Nov 07, 2024 | 3.27 | 3.355 | 3.165 | 3.18 | 406133.0 |
Nov 06, 2024 | 3.28 | 3.38 | 3.11 | 3.29 | 635257.0 |
Nov 05, 2024 | 3.13 | 3.37 | 3.04 | 3.25 | 771612.0 |
Nov 04, 2024 | 2.89 | 3.11 | 2.881 | 2.99 | 548441.0 |
Nov 01, 2024 | 2.78 | 2.92 | 2.77 | 2.89 | 416208.0 |
Oct 31, 2024 | 2.87 | 2.90 | 2.735 | 2.74 | 656732.0 |
Oct 30, 2024 | 2.86 | 3.08 | 2.85 | 2.87 | 667970.0 |
Oct 29, 2024 | 2.88 | 2.925 | 2.79 | 2.86 | 1.227M |
Oct 28, 2024 | 3.02 | 3.08 | 2.91 | 2.92 | 646787.0 |
Oct 25, 2024 | 3.05 | 3.12 | 2.95 | 2.98 | 330280.0 |
Oct 24, 2024 | 3.05 | 3.115 | 2.98 | 3.04 | 388910.0 |
Oct 23, 2024 | 3.26 | 3.295 | 3.01 | 3.06 | 1.437M |
Oct 22, 2024 | 3.21 | 3.335 | 3.19 | 3.31 | 522939.0 |
Oct 21, 2024 | 3.33 | 3.34 | 3.17 | 3.21 | 623184.0 |
Oct 18, 2024 | 3.20 | 3.415 | 3.16 | 3.31 | 572016.0 |
Oct 17, 2024 | 3.40 | 3.41 | 3.13 | 3.22 | 849742.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.27
Minimum
Oct 13 2022
44.80
Maximum
Jun 22 2020
11.57
Average
4.86
Median
Jul 05 2023
Price Benchmarks
Regeneron Pharmaceuticals Inc | 747.37 |
Vanda Pharmaceuticals Inc | 4.905 |
Ligand Pharmaceuticals Inc | 117.46 |
Agios Pharmaceuticals Inc | 55.30 |
ADMA Biologics Inc | 21.54 |
Price Related Metrics
Price to Book Value | 1.394 |
Earnings Yield | -55.42% |
Market Cap | 135.80M |